Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4005 USD | -10.22% |
|
-14.70% | -68.21% |
06-26 | Transcript : BioVie Inc. - Special Call | |
06-25 | BioVie Inc. Presents Protocol Design of Upcoming SUNRISE-PD Phase 2 Trial of Bezisterim in Patients with Early Parkinson's Disease at ATMRD 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
24.48M | - | - | - | - | - | |
121B | ||||||
113B | ||||||
26.02B | - | |||||
19.39B | - | |||||
15.91B |
- Stock Market
- Equities
- BIVI Stock
- Charts BioVie Inc.
- Sector Chart